vs

Side-by-side financial comparison of Consensus Cloud Solutions, Inc. (CCSI) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $87.1M, roughly 1.9× Consensus Cloud Solutions, Inc.). Consensus Cloud Solutions, Inc. runs the higher net margin — 23.5% vs -82.0%, a 105.5% gap on every dollar of revenue. On growth, Consensus Cloud Solutions, Inc. posted the faster year-over-year revenue change (0.1% vs -22.7%). Consensus Cloud Solutions, Inc. produced more free cash flow last quarter ($7.3M vs $-36.6M). Over the past eight quarters, Consensus Cloud Solutions, Inc.'s revenue compounded faster (-0.6% CAGR vs -11.5%).

Consensus Cloud Solutions, Inc. is a provider of cloud-based secure information delivery and digital workflow solutions. Its core offerings include encrypted digital fax, secure document exchange, and process automation tools, serving clients across healthcare, legal, financial services and enterprise sectors, with a primary operating market in North America.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

CCSI vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.9× larger
PTCT
$164.7M
$87.1M
CCSI
Growing faster (revenue YoY)
CCSI
CCSI
+22.8% gap
CCSI
0.1%
-22.7%
PTCT
Higher net margin
CCSI
CCSI
105.5% more per $
CCSI
23.5%
-82.0%
PTCT
More free cash flow
CCSI
CCSI
$44.0M more FCF
CCSI
$7.3M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
CCSI
CCSI
Annualised
CCSI
-0.6%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCSI
CCSI
PTCT
PTCT
Revenue
$87.1M
$164.7M
Net Profit
$20.5M
$-135.0M
Gross Margin
80.0%
Operating Margin
41.1%
-43.3%
Net Margin
23.5%
-82.0%
Revenue YoY
0.1%
-22.7%
Net Profit YoY
13.5%
-104.8%
EPS (diluted)
$1.06
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCSI
CCSI
PTCT
PTCT
Q4 25
$87.1M
$164.7M
Q3 25
$87.8M
$211.0M
Q2 25
$87.7M
$178.9M
Q1 25
$87.1M
$1.2B
Q4 24
$87.0M
$213.2M
Q3 24
$87.8M
$196.8M
Q2 24
$87.5M
$186.7M
Q1 24
$88.1M
$210.1M
Net Profit
CCSI
CCSI
PTCT
PTCT
Q4 25
$20.5M
$-135.0M
Q3 25
$22.1M
$15.9M
Q2 25
$20.8M
$-64.8M
Q1 25
$21.2M
$866.6M
Q4 24
$18.1M
$-65.9M
Q3 24
$21.1M
$-106.7M
Q2 24
$23.9M
$-99.2M
Q1 24
$26.4M
$-91.6M
Gross Margin
CCSI
CCSI
PTCT
PTCT
Q4 25
80.0%
Q3 25
80.0%
Q2 25
79.9%
Q1 25
79.3%
Q4 24
79.5%
Q3 24
79.9%
Q2 24
80.4%
Q1 24
80.7%
Operating Margin
CCSI
CCSI
PTCT
PTCT
Q4 25
41.1%
-43.3%
Q3 25
43.2%
1.4%
Q2 25
44.5%
-19.5%
Q1 25
43.0%
82.5%
Q4 24
38.4%
-76.2%
Q3 24
43.8%
-27.7%
Q2 24
45.6%
-21.5%
Q1 24
42.7%
-21.6%
Net Margin
CCSI
CCSI
PTCT
PTCT
Q4 25
23.5%
-82.0%
Q3 25
25.2%
7.5%
Q2 25
23.7%
-36.3%
Q1 25
24.3%
73.7%
Q4 24
20.8%
-30.9%
Q3 24
24.1%
-54.2%
Q2 24
27.3%
-53.1%
Q1 24
29.9%
-43.6%
EPS (diluted)
CCSI
CCSI
PTCT
PTCT
Q4 25
$1.06
$-1.63
Q3 25
$1.15
$0.20
Q2 25
$1.07
$-0.83
Q1 25
$1.07
$10.04
Q4 24
$0.92
$-0.85
Q3 24
$1.09
$-1.39
Q2 24
$1.24
$-1.29
Q1 24
$1.37
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCSI
CCSI
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$74.7M
$1.9B
Total DebtLower is stronger
$558.4M
Stockholders' EquityBook value
$13.8M
$-205.3M
Total Assets
$663.8M
$2.9B
Debt / EquityLower = less leverage
40.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCSI
CCSI
PTCT
PTCT
Q4 25
$74.7M
$1.9B
Q3 25
$97.6M
$1.7B
Q2 25
$57.9M
$2.0B
Q1 25
$53.4M
$2.0B
Q4 24
$33.5M
$1.1B
Q3 24
$54.6M
$1.0B
Q2 24
$49.2M
$1.1B
Q1 24
$61.5M
$884.8M
Total Debt
CCSI
CCSI
PTCT
PTCT
Q4 25
$558.4M
Q3 25
$578.6M
Q2 25
$578.2M
Q1 25
$583.7M
Q4 24
$593.0M
Q3 24
$612.5M
Q2 24
$642.8M
Q1 24
$671.7M
Stockholders' Equity
CCSI
CCSI
PTCT
PTCT
Q4 25
$13.8M
$-205.3M
Q3 25
$-2.6M
$-155.8M
Q2 25
$-26.5M
$-206.5M
Q1 25
$-49.4M
$-185.8M
Q4 24
$-79.5M
$-1.1B
Q3 24
$-93.2M
$-1.1B
Q2 24
$-124.4M
$-980.2M
Q1 24
$-151.8M
$-893.9M
Total Assets
CCSI
CCSI
PTCT
PTCT
Q4 25
$663.8M
$2.9B
Q3 25
$675.0M
$2.6B
Q2 25
$641.5M
$2.6B
Q1 25
$629.6M
$2.7B
Q4 24
$602.2M
$1.7B
Q3 24
$622.5M
$1.8B
Q2 24
$608.5M
$1.9B
Q1 24
$620.8M
$1.8B
Debt / Equity
CCSI
CCSI
PTCT
PTCT
Q4 25
40.54×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCSI
CCSI
PTCT
PTCT
Operating Cash FlowLast quarter
$15.2M
$-34.3M
Free Cash FlowOCF − Capex
$7.3M
$-36.6M
FCF MarginFCF / Revenue
8.4%
-22.3%
Capex IntensityCapex / Revenue
9.1%
1.4%
Cash ConversionOCF / Net Profit
0.74×
TTM Free Cash FlowTrailing 4 quarters
$105.9M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCSI
CCSI
PTCT
PTCT
Q4 25
$15.2M
$-34.3M
Q3 25
$51.6M
$-66.3M
Q2 25
$28.3M
$-58.3M
Q1 25
$40.9M
$870.1M
Q4 24
$11.1M
$-30.0M
Q3 24
$41.6M
$-77.0M
Q2 24
$24.4M
$-71.5M
Q1 24
$44.7M
$70.8M
Free Cash Flow
CCSI
CCSI
PTCT
PTCT
Q4 25
$7.3M
$-36.6M
Q3 25
$44.4M
$-69.7M
Q2 25
$20.3M
$-59.6M
Q1 25
$33.7M
$868.4M
Q4 24
$3.1M
$-33.8M
Q3 24
$33.6M
$-77.5M
Q2 24
$15.8M
$-78.8M
Q1 24
$35.8M
$61.2M
FCF Margin
CCSI
CCSI
PTCT
PTCT
Q4 25
8.4%
-22.3%
Q3 25
50.6%
-33.1%
Q2 25
23.2%
-33.3%
Q1 25
38.7%
73.8%
Q4 24
3.6%
-15.8%
Q3 24
38.3%
-39.4%
Q2 24
18.1%
-42.2%
Q1 24
40.6%
29.1%
Capex Intensity
CCSI
CCSI
PTCT
PTCT
Q4 25
9.1%
1.4%
Q3 25
8.2%
1.6%
Q2 25
9.1%
0.7%
Q1 25
8.3%
0.1%
Q4 24
9.2%
1.8%
Q3 24
9.1%
0.3%
Q2 24
9.8%
4.0%
Q1 24
10.1%
4.6%
Cash Conversion
CCSI
CCSI
PTCT
PTCT
Q4 25
0.74×
Q3 25
2.34×
-4.17×
Q2 25
1.36×
Q1 25
1.94×
1.00×
Q4 24
0.62×
Q3 24
1.97×
Q2 24
1.02×
Q1 24
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons